William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) database. Learn more at ProtectedPCI.com.
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for Ventricular Assist Devices (VAD). VADs are a type of hemodynamic support device that helps increase blood flow in people who have ventricles that don't work properly.
-
-
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital...
-
Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va., discusses a complex, high-risk percutaneous coronary intervention (PCI) case where...
-
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device (LVAD) for patients with...
News | Hemodynamic Support Devices | September 20, 2018
September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ)...
Videos | Hemodynamic Support Devices | August 31, 2018
Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va.,...
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
July 17, 2018 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive...
Image courtesy of CorWave
News | Ventricular Assist Devices (VAD) | July 11, 2018
July 11, 2018 — French-based CorWave announced that its CALYPSO program has received 14 million euros to develop...
Two versions of the Abiomed Impella percutaneous ventricular assist device displayed at ACC 2018. Impella is the only device that currently has a FDA indication for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | July 08, 2018 | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia...
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.
Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor
About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients...
Feature | Ventricular Assist Devices (VAD) | June 04, 2018
June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its...
News | Ventricular Assist Devices (VAD) | May 23, 2018
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...
Technology | Ventricular Assist Devices (VAD) | April 02, 2018
April 2, 2018 — Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval...
Videos | Heart Failure | March 23, 2018
David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit,...
News | Ventricular Assist Devices (VAD) | March 13, 2018
March 13, 2018 — At two years of follow-up, severely ill patients with advanced...
News | Hemodynamic Support Devices | February 15, 2018
February 15, 2018 — Abiomed Inc. announced that it received an expanded U.S. Food and Drug Administration (FDA) Pre-...
Feature | Hemodynamic Support Devices | February 14, 2018
February 14, 2018 — Abiomed Inc. announced it received an expanded U.S. Food and Drug Administration (FDA) pre-...
